Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study | The BMJ
Case 641 --Clinical Immunopathology Case
Rheumatoid Associated Autoantibodies in COVID-19 Patients | JIR
Diagnosis and Management of Rheumatoid Arthritis | AAFP
Rheumatoid Factor Is Negative: What Does It Mean?
Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis Yarlagadda LD, Jacob R, Rajasekhar D L, Iyyapu KM, S. Kompella SB, Madrol VB, Sreedevi N N, Khan SA,
Oman Medical Journal-Archive
Clinical Characteristics Of Rheumatoid Factor-Positive Or Negative Subsets Of Anti-Citrullinated Peptide/Protein Antibody-Negative Rheumatoid Arthritis - ACR Meeting Abstracts
Case Presentation on Rheumatoid athrities
Frontiers | Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity
What Is the Rheumatoid Factor Blood Test?
Prevalence and relevant factors of positive RF in brucellosis patients with arthralgia | PLOS Neglected Tropical Diseases
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study | The BMJ
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study | The BMJ
Rheumatoid Arthritis and Osteoarthritis: How to Assess Patients
Rheumatoid factor (RF)
PDF) Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis
Autoantibodies in early rheumatoid arthritis: Brasília cohort - results of a three-year serial analysis
Rheumatoid arthritis: risk factors, clinical signs, and treatment - Page 2 of 3 - Clinical Advisor
Frontiers | Signal Transducer and Activator of Transcription 3 Hyperactivation Associates With Follicular Helper T Cell Differentiation and Disease Activity in Rheumatoid Arthritis
Case 897 --Clinical Immunopathology Case
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study | The BMJ
An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis | NEJM
Rheumatoid arthritis | Nature Reviews Disease Primers
